IMPACT of PCSK9 inhibition on clinical outcome in patients during the inflammatory stage of the SARS-COV-2 infection: Rationale and protocol of the IMPACT-SIRIO 5 study
暂无分享,去创建一个
E. Navarese | J. Kubica | J. Pinkas | A. Kubica | R. Junik | P. Adamski | Przemysław Podhajski | P. Magielski | Piotr Adamski | Przemysław Magielski